← Back to Search

Perioperative Geriatrics Intervention for Pancreatic Cancer

N/A
Waitlist Available
Led By Ryan Nipp, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 65 or older
Diagnosed with pancreatic, esophageal, rectal, colon, hepatobiliary, or gastric cancer (including patients with prior diagnosis of another cancer)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This study is evaluating whether a surgical procedure can be done safely for older patients with cancer.

Eligible Conditions
  • Pancreatic Cancer
  • Esophageal Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Colon Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Length Of Stay
Secondary outcome measures
30-day readmission rate
Change In Activities of Daily Living (ADLs) / Instrumental Activities of Daily Living (IADLs) From Baseline To Post-Intervention
Change In Patients' Depression From Baseline To Post-Intervention
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Perioperative Geriatrics InterventionExperimental Treatment1 Intervention
Evaluation with a board-certified geriatric clinician, both pre- and post-operatively.
Group II: Standard CareActive Control1 Intervention
Usual care participants will not meet with a geriatric clinician perioperatively, but may receive a geriatric consult upon request or at the discretion of their treating clinician(s).

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,924 Previous Clinical Trials
13,193,263 Total Patients Enrolled
National Comprehensive Cancer NetworkNETWORK
115 Previous Clinical Trials
7,475 Total Patients Enrolled
Ryan Nipp, MDPrincipal InvestigatorMassachusetts General Hospital
4 Previous Clinical Trials
574 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~19 spots leftby Mar 2025